Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System

A8 virus (A8-V) is a molecular clone of the neuropathogenic FrC6 virus derived from the Friend murine leukemia virus (F-MuLV). The A8-V infects endothelia and microglia in the brain. We constructed a gene transfer system with the A8-V gene. Pseudotyped virus carrying the surface protein of A8-V (A8-...

Full description

Bibliographic Details
Main Authors: Rihito Watanabe M.D., Sayaka Takase-Yoden, Hidefumi Fukumitsu, Kazuyuki Nakajima
Format: Article
Language:English
Published: SAGE Publishing 2002-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/000000002783985684
id doaj-7bd463dc8f5641fc92eb3853093fd41c
record_format Article
spelling doaj-7bd463dc8f5641fc92eb3853093fd41c2020-11-25T03:29:20ZengSAGE PublishingCell Transplantation0963-68971555-38922002-07-011110.3727/000000002783985684Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector SystemRihito Watanabe M.D.0Sayaka Takase-Yoden1Hidefumi Fukumitsu2Kazuyuki Nakajima3Institute of Life Science, Soka University, Tangi-cho 1-236, Hachioji, Tokyo, 192-8577, JapanInstitute of Life Science, Soka University, Tangi-cho 1-236, Hachioji, Tokyo, 192-8577, JapanInstitute of Life Science, Soka University, Tangi-cho 1-236, Hachioji, Tokyo, 192-8577, JapanInstitute of Life Science, Soka University, Tangi-cho 1-236, Hachioji, Tokyo, 192-8577, JapanA8 virus (A8-V) is a molecular clone of the neuropathogenic FrC6 virus derived from the Friend murine leukemia virus (F-MuLV). The A8-V infects endothelia and microglia in the brain. We constructed a gene transfer system with the A8-V gene. Pseudotyped virus carrying the surface protein of A8-V (A8-SU) transduced the β-glactosidase gene incorporated in the retroviral vector efficiently to cultured microglial cells derived from newborn rats. Ex vivo gene transferred microglial cells were then injected into the right hemi-sphere of 3-day-old and 3-week-old rat brains. All of the rats examined at 4 weeks after the injection contained the labeled microglial cells in the brain (7/7 and 5/5 of the rats injected at 3 days and 3 weeks, respectively). None of the rats showed pathological changes in the whole body investigated, including the central nervous system, 4 weeks after transplantation of the labeled microglial cells.https://doi.org/10.3727/000000002783985684
collection DOAJ
language English
format Article
sources DOAJ
author Rihito Watanabe M.D.
Sayaka Takase-Yoden
Hidefumi Fukumitsu
Kazuyuki Nakajima
spellingShingle Rihito Watanabe M.D.
Sayaka Takase-Yoden
Hidefumi Fukumitsu
Kazuyuki Nakajima
Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System
Cell Transplantation
author_facet Rihito Watanabe M.D.
Sayaka Takase-Yoden
Hidefumi Fukumitsu
Kazuyuki Nakajima
author_sort Rihito Watanabe M.D.
title Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System
title_short Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System
title_full Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System
title_fullStr Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System
title_full_unstemmed Cell Transplantation to the Brain with Microglia Labeled by Neuropathogenic Retroviral Vector System
title_sort cell transplantation to the brain with microglia labeled by neuropathogenic retroviral vector system
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2002-07-01
description A8 virus (A8-V) is a molecular clone of the neuropathogenic FrC6 virus derived from the Friend murine leukemia virus (F-MuLV). The A8-V infects endothelia and microglia in the brain. We constructed a gene transfer system with the A8-V gene. Pseudotyped virus carrying the surface protein of A8-V (A8-SU) transduced the β-glactosidase gene incorporated in the retroviral vector efficiently to cultured microglial cells derived from newborn rats. Ex vivo gene transferred microglial cells were then injected into the right hemi-sphere of 3-day-old and 3-week-old rat brains. All of the rats examined at 4 weeks after the injection contained the labeled microglial cells in the brain (7/7 and 5/5 of the rats injected at 3 days and 3 weeks, respectively). None of the rats showed pathological changes in the whole body investigated, including the central nervous system, 4 weeks after transplantation of the labeled microglial cells.
url https://doi.org/10.3727/000000002783985684
work_keys_str_mv AT rihitowatanabemd celltransplantationtothebrainwithmicroglialabeledbyneuropathogenicretroviralvectorsystem
AT sayakatakaseyoden celltransplantationtothebrainwithmicroglialabeledbyneuropathogenicretroviralvectorsystem
AT hidefumifukumitsu celltransplantationtothebrainwithmicroglialabeledbyneuropathogenicretroviralvectorsystem
AT kazuyukinakajima celltransplantationtothebrainwithmicroglialabeledbyneuropathogenicretroviralvectorsystem
_version_ 1724579936915685376